Filing Flows › Sanofi (SNY) › Q2 2025
Sanofi (SNY) Q2 2025 earnings results (second quarter 2025)
6-K filed Jul 31, 2025
Sanofi (SNY) reported revenue of $10.0B for the second quarter 2025 (Q2 2025), +6% from a year earlier. Operating margin was 14.7%, net earnings $3.9B (39.5% of revenue).
Sanofi, Q2 2025: revenue $10.0B (+6% year over year), operating margin 14.7%, net earnings $3.9B. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.0B | — | +6% |
| Gross profit | $7.7B | — | +8% |
| Operating profit | $1.5B | — | -4% |
| Net earnings | $3.9B | — | +253% |
What changed
Revenue was €10.0B in Q2 2025, up 6% year over year.
Gross margin was 77.5%, up 1.5 points from a year earlier. Operating profit was €1.5B, a 14.7% margin (down 1.5 points year over year). Operating profit fell €0.06B even though revenue rose €0.57B versus a year earlier, so costs grew faster than sales. Operating expenses grew 11% against revenue growth of 6%. The fastest-growing cost line was Research & development (+15%). Net earnings were €3.9B, up 254% year over year. The effective tax rate was 5.5%. Non-operating items added €2.7B, 65% of pre-tax earnings, so the bottom line overstates operating performance.
Questions
What was Sanofi's revenue in the second quarter 2025?
Sanofi (SNY) reported revenue of $10.0B for the second quarter 2025 (Q2 2025), +6% from a year earlier.
Was Sanofi profitable in the second quarter 2025?
Operating profit was $1.5B (14.7% of revenue) and net earnings $3.9B.
Source: Sanofi 6-K on SEC EDGAR.